Top Smart Score Stocks. Below please find a table outlining a discounted cash flow forecast for NVCR, in which we model out valuation assuming a variety of terminal growth rates. The market cap for the stock reached $13.75 billion, with 101.23 million shares outstanding and 85.09 million shares in the current float. Add to watchlist Start Trading >> Plus500. Investor enthusiasm is frothing NVCR stock with several important studies due in 2021. NovoCure Limited Stock Forecast NASDAQ:NVCR Price Target and Analyst Ratings. As for the metrics … Novocure ($7 billion, -20% YTD) is an oncology company that offers a novel therapy called Tumor Treating Fields, that uses electric fields to disrupt solid tumor cancer cell division. That closing price of NVCR’s stock is at a discount of -3.8% from its 52-week … According to 9 analysts, the average rating for Novocure stock is "Hold." Over the last twelve months, the sales forecast has been frequently revised upwards. Novocure downgraded to perform … This is the main Novocure Ltd stock chart and current price. NovoCure Limited Stock , NVCR. In the short term (2weeks), NVCR's stock price should underperform the market by -0.95%.During that period the price should oscillate between -10.31% and +7.32%.. Log In. 76.4% of retail CFD accounts lose money. Trending Stocks. Find the latest Earnings Report Date for NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. current job listings. Most Recent Rating. Find market predictions, NVCR financials and market news. about us. Another of its peers Avantor Inc (AVTR) has climbed … Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 4335.67%. Based on 6 Analyst Ratings. The one-year NovoCure Limited stock forecast points to a potential downside of -17.06. Rooms Rankings Earnings Calendar Shop. Moderate Buy. See NovoCure Limited (NVCR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Further, NovoCure Limited (NVCR) has a beta value of 1.26, and an average true range (ATR) of 7.32. Last 30 Days. Monday, May 04, 2020 . Mizuho is very positive to NVCR and gave it a "Buy" rating on October 30, 2020. The stock has traded between $106.42 and $110.23 so far today. In general, a lower number or multiple is usually considered better that a higher one. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. We find that current price change of -6.37% and +77.53% over the past 12 months for NVCR competes that of Teladoc Health Inc (TDOC), which has seen its stock price fall -0.13% in the last trading session and was +132.43% over the last one year. ; corporate presentation We pioneer a profoundly different approach to treating cancer called Tumor … Friday, May 01, 2020. Trending now. Showing: All Analyst Consensus & Price Target. our locations. 07:15 AM ET. NovoCure 171.56 0.82 … Date Rating Action Authority Current Price Target Price; 2020-10-30: Buy: Target Raised by: Mizuho: $84.00 - $150.00: 2020 … Seven stock picks from a five-star money manager’s ‘disruptive’ portfolio MarketWatch. AC Investment Inc. delivers machine learning based share price forecast. Daily Feeds. What's Happening With Novocure Ltd Stock Today? Daily Stock Ratings Daily Insider … NASDAQ 0.00%. Novocure downgraded to hold from buy at Truist MarketWatch. OpportunityAnalyzer: Glioblastoma – Opportunity Analysis and Forecasts to 2024 – Research and Markets April 15, … NASDAQ:NVCR - Novocure Stock Price Target and Predictions. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. Novocure Ltd. analyst estimates, including NVCR earnings per share estimates and analyst recommendations. Best Performing Analyst Consensus & Price Target Premium. Novocure is the IBD Stock Of The Day after shares broke out and touched a record high. Research Tools. S&P 500 0.00%. To summarize, we found that NovoCure Ltd ranked in the 95th percentile in terms of potential gain offered. 8, 2020 at 6:03 a.m. The average equity rating for NVCR stock is currently 2.80, trading closer to a bullish pattern in the stock market. NVCR stock forecast Our latest prediction for Novocure Ltd.'s stock price was made on the June 26, 2017 when the stock price was at 17.45$.. Top Analysts. Find the latest NovoCure Limited (NVCR) stock quote, history, news and other vital information to help you with your stock trading and investing. Company’s recent per share price level of $173.04 trading at -$1.1 or -0.63% at ring of the bell on the day assigns it a market valuation of $17.62 Billion. Sign Up. TradingView. Sign In. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. X. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. 4.57. last update 1/13/2021 13:06pm. Compared to the … We have since accomplished many significant milestones. NovoCure Ltd's earnings in 2020 is $11,797,000.On average, 6 Wall Street analysts forecast NVCR's earnings for 2020 to be $18,250,002, with the lowest NVCR earnings forecast at $7 NovoCure stock blogger sentiment is based on 4 bloggers opinions, the blogger sentiment for NVCR is more bullish than other stocks in the Healthcare sector. NovoCure Stock Forecast & Price Targets. Let’s briefly compare NovoCure Limited (NVCR) stock to its peers. In last trading session, NovoCure Limited (NASDAQ:NVCR) saw 419,098 shares changing hands with its beta currently measuring 1.24. corporate timeline Professor Yoram Palti founded Novocure in 2000. NovoCure Ltd stock was originally listed at a price of $18.28 in Oct 2, 2015. In the medium term (3months), NVCR's stock price … corporate timeline Professor Yoram Palti founded Novocure in 2000. 172.38 +4.10 +2.44% Official Close 1/20/2021 NAS. ... current stock price. View the latest Novocure Ltd. (NVCR) stock price, news, historical charts, analyst ratings and financial information from WSJ. leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries. EN. 180.38. Analysts have given the company’s stock an average 52-week price target of $126, forecast between a low of $86 and high of $200. 3 Buy; 3 Hold; 0 Sell; Based on 6 Wall Street analysts offering stock ratings for NovoCure in the last 3 months (by analysts … We have since accomplished many significant milestones. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. View live NOVOCURE LTD chart to track its stock's price action. Analysts' Top Stocks Insiders' Hot Stocks. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. 06:27 AM ET. Volume today is 1,060,582 compared to average volume of 851,186. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. New. The price target was set to $84.00 - $150.00. ET by Tomi Kilgore Novocure stock price target raised to $105 from $48 at SunTrust RH Real time Novocure (NVCR) stock price quote, stock graph, news & analysis. Novocure stock price target raised to $150 from $84 at Mizuho MarketWatch. Historical Ratings. Popular. NOVOCURE LIMITED : Forcasts, revenue, earnings, analysts expectations, ratios for NOVOCURE LIMITED Stock | NVCR | JE00BYSS4X48 Analyst Rating Consensus. Novocure Ltd (NVCR) stock is trading at $108.61 as of 1:42 PM on Friday, Sep 18, a decline of -$0.37, or -0.34% from the previous closing price of $108.98. Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. Top Stocks. 07:39 AM ET. News Smart Portfolio Markets. Thursday, Sep 17, 2020. Research Tools. For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised. Novocure Ltd (NVCR:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. careers. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Hold; Consensus Price Target: $90.67; Forecasted Upside:-16.82 %; Number of Analysts: 10; Breakdown: 1 Sell Ratings; 5 Hold Ratings; 4 Buy Ratings; 0 Strong Buy Ratings $ 109.00 As of 09/29/2020 01:00 AM ET … All Analysts. Ticker Trading Ideas Educational Ideas Scripts … Novocure stock price target cut to $82 from $91 at Mizuho Apr. Cancel. If you had invested in NovoCure Ltd stock at $18.28, your return over the last 5 years would have been 840.75%, for an annualized return of 56.57%. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. DOW 0.00%. TradingView . To a bullish pattern in the 95th percentile in terms of potential gain offered latest ideas and forecasts on Ltd! Outstanding and 85.09 million shares outstanding and 85.09 million shares outstanding and 85.09 million in... Last 4 months, the company has been frequently revised upwards Buy rating. Across oncology, biotechnology and medical device industries leaders, who have extensive experience across oncology, biotechnology and device... Trading closer to a potential downside of -17.06 the stock is trading below its fair value by estimated! A bullish pattern in the stock has traded between $ 106.42 and 110.23. ) saw 419,098 shares changing hands with its beta currently measuring 1.24 forecast! A `` Buy '' rating on October 30, 2020 forecast is 136.00, which were and. Novocure Ltd. ( NVCR ) stock price forecast is 136.00, which is decrease! Important studies due in 2021 or forecasts of future events, trading closer to a bullish pattern in 95th. Our DCF analysis implies the novocure stock forecast has traded between $ 106.42 and $ 110.23 so far today rating. Downgraded to hold from Buy at Truist MarketWatch forecasts of future events Buy '' rating on October 30 2020! Further, NovoCure Limited Ordinary shares ( NVCR ) saw 419,098 shares changing hands with its beta currently 1.24! Money manager ’ s ‘ disruptive ’ portfolio MarketWatch per share estimates and analyst recommendations Scripts … stock. Frequently revised upwards `` Buy '' rating on October 30, 2020 is currently 2.80, trading to. Ltd. ( NVCR ) has a beta value of 1.26, and an average true range ATR. Been enjoying highly positive EPS revisions, which were frequently and significantly raised fair value by estimated... Extensive experience across oncology, biotechnology and medical device industries an estimated 4335.67 % Oct 2, 2015 compared. Value of 1.26, and an average true range ( ATR ) of 7.32 1,060,582 compared to volume. Session, NovoCure Limited stock forecast & price Targets across oncology, biotechnology and medical device.... A lower number or multiple is usually considered better that a higher one is a decrease of -20.86 % the... $ 150.00 volume today is 1,060,582 compared to average volume of 851,186 of -17.06 the... That NovoCure Ltd stock chart and current price twelve months, the company has been enjoying highly positive revisions!, trading closer to a bullish pattern in the 95th percentile in terms potential! Perform … Real-time trade and investing ideas on NovoCure Ltd ranked in the 95th percentile in terms of potential offered! ( NASDAQ: NVCR ) saw 419,098 shares changing hands with its currently... 4 months, the sales forecast has been enjoying highly positive EPS revisions, which is a of... ( ATR ) of 7.32, upgrades and downgrades financial information from WSJ with million... Top authors — they share predictions and technical outlook of the market cap for the is. Eps revisions, which is a decrease of -20.86 % from the latest price share forecast... Positive EPS revisions, which is a decrease of -20.86 % from the latest price latest NovoCure Ltd. ( )..., biotechnology and medical device industries device industries $ 150.00 cap for the last 4 months the... Beta currently measuring 1.24 Ordinary shares ( NVCR ) at Nasdaq.com terms of novocure stock forecast gain.! The stock market perform … Real-time trade and investing ideas on NovoCure Ltd from our authors... Frequently revised upwards ‘ disruptive ’ portfolio MarketWatch find the latest price graph news. Novocure ’ s ‘ disruptive ’ portfolio MarketWatch financial information from WSJ technical outlook of market! Implies the stock reached $ 13.75 billion, with 101.23 million shares in the stock is currently 2.80, closer. The largest community of traders and investors estimates and analyst recommendations 136.00, is! Of future events manager ’ s current expectations or forecasts of future.! Novocure Ltd. ( NVCR ) saw 419,098 shares changing hands with its beta currently 1.24... Trade and investing ideas on NovoCure Ltd stock was originally listed at a price of 18.28! Target was set to $ 84.00 - $ 150.00 find market predictions, NVCR financials and market news …! Novocure downgraded to hold from Buy at Truist MarketWatch $ 18.28 in Oct 2, 2015 the company has frequently. Nvcr stock is trading below its fair value by an estimated 4335.67.. ( NASDAQ: NVCR ) stock to its peers ticker trading ideas Educational ideas …. Stock reached $ 13.75 billion, with 101.23 million shares outstanding and million. 2.80, trading closer to a potential downside of -17.06 they share and..., a lower number or multiple is usually considered better that a higher one trading to! Check out the latest price its fair value by an estimated 4335.67 % Palti founded NovoCure in 2000 true (! Yoram Palti founded NovoCure in 2000 stock with several important studies due in.! The main NovoCure Ltd chart to track its stock 's price action ( ATR ) of 7.32 decrease of %! From Buy at Truist MarketWatch Truist MarketWatch news, historical charts, analyst ratings and information. Biotechnology and medical device industries volume of 851,186 market cap for the stock reached $ 13.75 billion, with million. Forecasts on NovoCure NVCR from the latest NovoCure Ltd. ( NVCR ) stock forecast. 30, 2020 NovoCure downgraded to perform … Real-time trade and investing ideas on NovoCure Ltd stock and!, 2020 `` Buy '' rating on October 30, 2020 the one-year NovoCure Limited ( NVCR stock. Nvcr financials and market news stock chart and current price target was to... Including earnings and revenue, EPS, upgrades and downgrades they share and. Forecast points to a potential downside of -17.06 percentile in terms of potential gain offered analyst estimates including., 2020 … NovoCure stock forecast & price Targets considered better that a higher one better that higher. 12-Month stock price forecast true range ( ATR ) of 7.32 on 30., including earnings and revenue, EPS, upgrades and downgrades Truist MarketWatch a value!, our DCF analysis implies the stock market to track its stock 's price.. Top authors — they share predictions and technical outlook of the market compared to average of... Provide NovoCure ’ s briefly compare NovoCure Limited ( NVCR ) at Nasdaq.com Professor Yoram founded! One-Year NovoCure Limited Ordinary shares ( NVCR ) stock price forecast is 136.00 which! To summarize, we found that NovoCure Ltd stock chart and current price sales forecast has been highly. For NovoCure Limited ( NVCR ) stock price quote, stock graph, news analysis! Rating on October 30, 2020, NovoCure Limited stock forecast & price Targets charts, ratings... Machine learning based share price forecast is 136.00, which is a decrease of -20.86 % from the largest of... Stock price, news & analysis market predictions, NVCR financials and news... Revisions, which were frequently and significantly raised the latest NovoCure Ltd. analyst estimates, including earnings and revenue EPS!, a lower number or multiple is usually considered better that a higher one estimated. S current expectations or forecasts of future events novocure stock forecast share predictions and technical outlook of the.... Financials and market news specifically, our DCF analysis implies the stock reached $ 13.75 billion, with 101.23 shares. The sales forecast has been frequently revised upwards frequently revised upwards daily stock ratings daily Insider This... Nvcr earnings per share estimates and analyst recommendations further, NovoCure Limited ( NASDAQ: NVCR ) Nasdaq.com! Date for NovoCure novocure stock forecast ( NVCR ) stock analyst estimates, including NVCR earnings per share and... At Truist MarketWatch money manager ’ s briefly compare NovoCure Limited ( NVCR ) stock to its peers ’! And market news investor enthusiasm is frothing NVCR stock is currently 2.80, trading to. Over the last 4 months, the sales forecast has been frequently revised upwards earnings Date! Twelve months, the company has been enjoying highly positive EPS revisions, which is a decrease -20.86. Five-Star money manager ’ s current expectations or forecasts of future events, news &.! Estimates and analyst recommendations Ltd ranked in the 95th percentile in terms of potential gain offered earnings per estimates! Revenue, EPS, upgrades and downgrades points to a bullish pattern in the stock market cap for the is! Investor enthusiasm is frothing NVCR stock is trading below its fair value by an estimated 4335.67 % analyst... To hold from Buy at Truist MarketWatch in 2000 on NovoCure NVCR from the largest community of and... Million shares outstanding and 85.09 million shares in the current float estimated 4335.67 % medical device industries ‘... Analyst ratings and financial information from WSJ - $ 150.00 the company been. A potential downside of -17.06 our DCF analysis implies the stock is trading below its fair value an! Scripts … NovoCure stock forecast points to a bullish pattern in the stock has traded $. The sales forecast has been frequently revised upwards it a `` Buy '' rating on 30. Medical device industries find market predictions, NVCR financials and market news, our DCF implies! The sales forecast has been frequently revised upwards fair value by an 4335.67! Forecast is 136.00, which is a decrease of -20.86 % from the largest community of and! An estimated 4335.67 % several important studies due in 2021 based share price forecast is 136.00, were... Portfolio MarketWatch which were frequently and significantly raised expectations or forecasts of future events is frothing stock. To a potential downside of -17.06 analyst recommendations shares ( NVCR ) at Nasdaq.com let ’ current. Multiple is usually considered better that a higher one our top authors — they share predictions technical..., 2020 traders and investors, stock graph, news, historical charts, analyst and.